Big Data Engineer Trials 
Roots Analysis
JANUARY 28, 2024
Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
JUNE 26, 2023
Pérez-Stable, MD This year’s annual Steering Committee meeting for the NIH Pragmatic Trials Collaboratory featured health equity as a central topic of discussion. Going forward, there is also tremendous value in capturing more granular data on individuals’ heritage and background.
pharmaphorum
DECEMBER 10, 2020
UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with US clinical trial data specialist Phesi. The new agreement comes after a string of access deals with NHS trusts for patient data, and coincides with a bid by Sensyne to raise £27.5 It already has access to around 6.1
The Pharma Data
JANUARY 12, 2021
a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process.
pharmaphorum
SEPTEMBER 16, 2022
Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. It also bodes well for improving clinical trial success rates. A notable issue with clinical trials is the homogeneity of the patient database.
pharmaphorum
MAY 25, 2021
One of the main reasons to use RWE is to counter a common criticism of the large phase 3 trials that for so long have been the ‘gold standard’ when developing drugs and gaining authorisations from regulators. Savana is built following the highest privacy-by-design standards and with medical reliability engineered by doctors for doctors.
Expert insights. Personalized for you.
40 
Let's personalize your content